0001104659-23-102863.txt : 20230921
0001104659-23-102863.hdr.sgml : 20230921
20230921171211
ACCESSION NUMBER: 0001104659-23-102863
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230912
FILED AS OF DATE: 20230921
DATE AS OF CHANGE: 20230921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paradigm Biocapital Advisors LP
CENTRAL INDEX KEY: 0001855655
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 231269750
BUSINESS ADDRESS:
STREET 1: 767 THIRD AVENUE, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 646-970-2123
MAIL ADDRESS:
STREET 1: 767 THIRD AVENUE, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paradigm BioCapital International Fund Ltd.
CENTRAL INDEX KEY: 0001854392
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 231269748
BUSINESS ADDRESS:
STREET 1: C/O WALKERS CORPORATE LIMITED
STREET 2: 190 ELGIN AVENUE
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-9008
BUSINESS PHONE: (646) 970-2568
MAIL ADDRESS:
STREET 1: C/O WALKERS CORPORATE LIMITED
STREET 2: 190 ELGIN AVENUE
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-9008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Asefaw Senai
CENTRAL INDEX KEY: 0001994183
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 231269747
MAIL ADDRESS:
STREET 1: 767 THIRD AVENUE
STREET 2: 17TH FLOOR
CITY: NEW YORK CITY
STATE: NY
ZIP: 10017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paradigm BioCapital Advisors GP LLC
CENTRAL INDEX KEY: 0001994082
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 231269749
BUSINESS ADDRESS:
STREET 1: 767 THIRD AVENUE
STREET 2: 17TH FLOOR
CITY: NEW YORK CITY
STATE: NY
ZIP: 10017
BUSINESS PHONE: 646-970-2542
MAIL ADDRESS:
STREET 1: 767 THIRD AVENUE
STREET 2: 17TH FLOOR
CITY: NEW YORK CITY
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 BRANNAN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 780 BRANNAN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
3
1
tm2326131-2_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2023-09-12
0
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001855655
Paradigm Biocapital Advisors LP
767 THIRD AVENUE, 17TH FLOOR
NEW YORK
NY
10017
0
0
1
0
0001994082
Paradigm BioCapital Advisors GP LLC
767 THIRD AVENUE, 17TH FLOOR
NEW YORK
NY
10017
0
0
1
0
0001854392
Paradigm BioCapital International Fund Ltd.
767 THIRD AVENUE, 17TH FLOOR
NEW YORK
NY
10017
0
0
1
0
0001994183
Asefaw Senai
767 THIRD AVENUE, 17TH FLOOR
NEW YORK
NY
10017
0
0
1
0
Common Stock, par value $0.0001 per share
6490981
I
By: Paradigm BioCapital International Fund Ltd.
Common Stock, par value $0.0001 per share
1312619
I
By: One or more separately managed accounts
These securities are held directly by Paradigm BioCapital International Fund Ltd (the "Fund"). The Fund is a private investment vehicle. Paradigm BioCapital Advisors LP (the "Adviser") is the investment adviser of the Fund. Paradigm BioCapital Advisors GP LLC (the "Adviser GP") is the general partner of the Adviser. Senai Asefaw, M.D. is the managing member of the Adviser GP. Each Reporting Person disclaims beneficial ownership of all securities reported herein, except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.
These securities are held directly by one or more separately managed accounts managed by the Adviser. Each Reporting Person disclaims beneficial ownership of all securities reported herein, except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.
/s/ David Kim, as an authorized signatory of the Fund and the Adviser GP (for itself and on behalf of the Adviser)
2023-09-21
/s/ Senai Asefaw, M.D.
2023-09-21